Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder

Clinical Genetics

Volumn 58, Issue 1, 2000, Pages 31-40

  Comings, David E ^a   Gade Andavolu, Radhika ^a   Gonzalez, Nancy ^a   Wu, Shijuan ^a   Muhleman, Donn ^a   Blake, Hezekiah ^a   Chiu, F ^a   Wang, E ^a   Farwell, K ^a   Darakjy, S ^a   Baker, R ^a   Dietz, George ^a   Saucier, Gerard ^a,b   MacMurray, James P ^a,c  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF OREGON   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavior; Conduct disorder; Genes; Heterosis; Multifactorial; Oppositional defiant disorder; Polygenic; Psychiatric

Indexed keywords

ADENOSINE A2A RECEPTOR; AROMATASE; CHOLINERGIC RECEPTOR; DOPAMINE; NEUROTRANSMITTER; NICOTINIC RECEPTOR; NITRIC OXIDE SYNTHASE; NORADRENALIN; SEROTONIN;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; HUMAN; MAJOR CLINICAL STUDY; MULTIFACTORIAL INHERITANCE; MULTIVARIATE ANALYSIS; OPPOSITIONAL DEFIANT DISORDER; PRIORITY JOURNAL; RECEPTOR GENE;

ADOLESCENT; ADULT; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; CONDUCT DISORDER; HORMONES; HUMANS; MULTIVARIATE ANALYSIS; NEUROTRANSMITTER AGENTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 18244430469     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2000.580106.x     Document Type: Article

References (68)

1. Comings DE, Gade-Andavolu R, Gonzalez N et al. Comparison of the role of dopamine, serotonin, and noradrenergic genes in ADHD, ODD and conduct disorder. Multivariate regression analysis of 20 genes. Clin Genet 2000: in press2E
2. Gillis JJ, Gigler JW, Pennington BF, DeFries JC. Attention deficit disorder in reading-disabled twins: evidence for a genetic etiology. J Abnorm Child Psychol 1992: 20: 343-348.
3. Hudziak JJ, Heah A, Reich W et al. Latent class and genetic analysis of DSM-IV attention-deficit/hyperactivity disorder. Am J Med Gen (Neuropsych Genet) 1997: 74: 567-568.
4. Sherman DK, McGue MK, Iacono WG. Twin concordance for attention deficit hyperactivity disorder: a comparison of teachers' and mothers' reports. Am J Psychiatry 1997: 154: 532-535.
5. Stevenson J. Evidence for a genetic etiology in hyperactivity. Behav Genet 1992: 22: 337-344.
6. Stevenson J, Pennington BF, Gilger JW, DeFries JC, Gillis JJ. Hyperactivity and spelling disability: testing for shared genetic aetiology. J Child Psychol Psychiatry 1993: 34: 1137-1152.
7. Nadder TS, Silberg JL, Eaves LJ, Maes HH, Meyer JM. Genetic effects on ADHD symptomatology in 7- to 13-year-old twins: results from a telephone survey. Behav Genet 1998: 28: 83-99.
8. Silberg J, Rutter M, Meyer J, Maes H, Hewitt J, Simonoff E, Pickles A, Loeber R, Eaves L. Genetic and environmental influences on the convariation between hyperactivity and conduct disorder in juvenile twins. J Child Psychol Psychiatry 1996: 37: 803-816.
9. Slutske WS, Heath AC, Dinwiddle SH, Madden PA, Bucholz KK, Dunne MP, Statham DJ, Martin NG. Modeling genetic and environmental influences in the etiology of conduct disorder: a study of 2,682 adult twin pairs. J Abnorm Psychol 1997: 106: 266-279.
10. Sherman DK, Iacono WG, McGue MK. Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity. J Am Acad Child Adolesc Psychiatry 1997: 36: 745-753.
11. Comings DE, Chen C, Wu S, Muhleman D. Association of the androgen receptor gene (AR) with ADHD and conduct disorder. Neuroreport 1999: 10: 1589-1592.
12. Haouas H, Morello D, Lavenu A, Billard M, Jasmin C, Boucheix C. Characterization of the 5′ region of the CD10/ neutral endopeptidase 24.11 gene. Biochem Biophys Res Comm 1995: 207: 933-942.
13. Watt VM, Willard HF. The human aminopeptidase N gene: isolation, chromosome localization, and DNA polymorphism analysis. Hum Genet 1990: 85: 651-654.
14. Wesnes K, Warburton DM. Smoking, nicotine and human performance. In: Balfour DJK, ed. Nicotine and the Tobacco Smoking Habit, Section 114. The International Encyclopedia of Pharmacology and Therapeutics. New York: Pergamon Press, 1984: 133-152.
15. Warburton DM. Nicotine as a cognitive enhancer. Prog Neuropsychopharmacol Biol Psychiatry 1992: 16: 181-191.
16. Balfour DJ. Fagerström KO. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharm Ther 1996: 72: 51-81.
17. Coger RW, Moe KL, Serafetinides EA. Attention deficit disorder in adults and nicotine dependence: psychobiological factors in resistance to recovery? J Psychoactive Drugs 1996: 28: 229-240.
18. Conners CK, Levin ED, Sparrow E et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull 1996: 32: 67-73.
19. Levin ED, Conners CK, Sparrow E et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 1996: 123: 55-63.
20. Wilens TE, Biederman J, Spencer TJ et al. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry 1999: 156 (12): 1931-1937.
21. Morelli M, Fenu S, Pinna A, DiChiara G. Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 1994: 251: 21-25.
22. Ferré S, Fredholm BB, Molerlli M, Popoli P, Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 1997: 20: 482-487.
23. Ledent C, Vaugeois J-M, Schiffmann SN et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997: 388: 674-678.
24. Haley JE, Wilcox GL, Chapman PF. The role of nitric oxide in hippocampal long-term potentiation. Neuron 1992: 8: 211-216.
25. Son H, Hawkins RD, Martin K et al. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 1996: 87: 1015-1023.
26. Nelson RJ, Demas GE, Huang PL et al. Behavioral abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 1995: 378: 383-386.
27. Tang Y-P, Shimizu E, Dube GR et al. Genetic enhancement of learning and memory in mice. Nature 1999: 401: 63-69.
28. Romero J, García L, Cebeira G, Zadrozny D, Fernández-Ruiz JJ, Ramos JA. The endogenous cannabinoid receptor ligand, anadamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. Life Sci 1995: 56: 2033-2040.
29. Comings DE, MacMurray JM. Different genes for susceptibility to drug versus alcohol dependence. Biol Psychiatry 1997: 42: 295S-296S.
30. Hickman D, Risch A, Buckle V et al. Chromosomal localization of human genes for arylamine N-acetyltransferase. Biochem J 1994: 297: 441-445.
31. Grant DM, Hughes NC, Janezic SA et al. Human acetyltransferase polymorphisms. Mutat Res 1997: 12: 61-70.
32. Smyth DG, Massey DE, Zakarian S, Finnie MDA. Enkephalins are stored in biologically active and inactive forms: isolation of α-N-acetyl peptides. Nature 1979: 279: 252-254.
33. Comings DE, Muhleman D, Wu S, MacMurray JP. Association of the N-α-acetyltransferase gene (NAT1) with mild and severe substance abuse. NeuroReport 2000: (in press).
34. Moffitt TE, Silva PA. IQ and delinquency: a direct test of the differential detection hypothesis. J Abnorm Psychol 1988: 97: 330-333.
35. Olweus D, Mattsson D, Schalling D, Löw H. Circulating testosterone levels and aggression in adolescent males: a casual analysis. Psychosom Med 1988: 50: 261-272.
36. Johnson JP, MacMurray J, Muhleman D, Comings DE. Association between the androgen receptor gene (GGC) triplet repeat polymorphism and aggressive, impulsive, and cognitive traits in white male polysubstance abusers. 2000: submitted.
37. Choong CS, Kemppainen JA, Zhou A-X, Wilson EM. Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocr 1996: 10: 1527-1535.
38. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995: 55: 1937-1940.
39. Giovannucci E, Stampfer MJ, Krithivas K et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997: 94: 3320-3323.
40. DeVries AC, Young WS, Nelson RJ. Reduced aggressive behaviour in mice with targeted disruption of the oxytocin gene. J Neuroendocrinol 1997: 9: 363-368.
41. Roy A, Virkkunen M, Guthrie S, Poland R, Linnoila M. Monamines, glucose metabolism, suicidal and aggressive behaviors. Psychopharmacol Bull 1986: 22: 661-665.
42. Virkkunen M, Rawlings R, Tokola R et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 1994: 51: 20-27.
43. Nemeroff CD. Corticotropin-releasing factor. In: Nemeroff CB, ed. Neuropeptides and Psychiatric Disorders. Washington, DC: American Psychiatric Press, 1991: 75-91.
44. Fukamauchi F, Wang YJ, Malaga N, Kusakabe M. Effects of cholecystokinin-B receptor antagonist on dopamine system in tenascin mutant mice. Neuroreport 1997: 8: 3919-3922.
45. Kobayashi S, Ohta M, Miyasaka K, Funakoshi A. Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats. Neurosci Lett 1996: 214: 61-64.
46. Trifiletti RR, Packard AM. Immune mechansims in pediatrie neuropsychiatric disorders. Tourette's syndrome, OCD, and PANDAS. Child Adolesc Psychiatry Clin North Am 1999: 8: 767-775.
47. Scott WK, Growdon JH, Roses AD, Haines JL, Pericak-Vance MA. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996: 347: 1185-1186.
48. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum, Publisher, 1988.
49. 6 receptor gene in schizophrenia. Am J Med Gen (Neuropsych Genet) 1998: 81: 503.
50. A receptor β3 (GABRB3) locus in the Angelman/Prader-Willi region (AS/PWS) of chromosome 15. Hum Mol Genet 1992: 1: 67.
51. Dawson E. Identification of a polymorphic triplet repeat marker for the brain cannabinoid receptor gene: use in linkage and association studies. Psychiatry Genet 1995: 5: S50.
52. Weiland S, Steinlein O. Dincucleotide polymorphism in the first intron of the human neuronal nicotinic acetylcholine receptor α4 subunit gene (CHRNA4). Clin Genet 1996: 50: 433-434.
53. Rupp C, Dang N, Ru N, Sobell JL. Examination of the NMDAR1 gene in schizophrenia. Am J Med Gen (Neuropsych Genet) 1997: 74: 631-632.
54. 2a receptor (A2aAR) gene: systematic mutation screening in patients with schizophrenia. J Neural Transm 1996: 103: 1447-1455.
55. Wang XL, Sim AHS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med 1996: 2: 41-45.
56. Weber JL, May PE. Dinucleotide repeat polymorphism at the PENK locus. Nucleic Acids Res 1990: 18: 2000.
57. Comings DE, Blake H. Dietz G et al. The proenkephalin gene (PENK) and opioid dependence. Neuroreport 1999: 10: 1133-1135.
58. Dietz AC, Doll MA, Hein DW. A restriction fragment length polymorphism assay that differentiates human N-acetylfransferase-1 (NAT1) alleles. Anal Biochem 1997: 253: 219-224.
59. del Senno L, Aguiari GL, Piva R. Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene. Hum Mol Genet 1992: 1: 354.
60. Comings DE, Muhleman D, Johnson P, MacMurray JP. Potential role of the estrogen receptor gene (ESR1) in anxiety. Mol Psychiatry 1999: 4: 374-377.
61. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res 1991: 19: 195.
62. Xu Y, Li H. An A to G polymorphism in the SHBG gene. Hum Mol Genet 1998: 3: 1443.
63. Liao W-X, Toy AC, Biswas A, Arulkumaran S, Ratnam SS. A new silent C to T polymorphism in the exon 3 of the oxytocin receptor gene. Clin Genet 1996: 50: 533-534.
64. Ishiguro H, Saito T, Shibuya H, Toru M, Arinami T. No association between C-45T polymorphism in the Sp1 binding site of the promoter region of the cholecystokinin gene and alcoholism. Psychiatry Res 1999: 85: 209-213.
65. Hoban PR, Kelsey AM. Pst I polymorphism with the 3′ untranslated region of the insulin gene detectable by the polymerase chain reaction (INS). Nucleic Acids Res 1991: 19: 4576.
66. Gade-Andavolu R, MacMurray J, Peters W, Comings DE. Association of PST-1 polymorphism in insulin gene (INS3) with obesity and novelty seeking. Mol Psychiatry 1999: 4: 106.
67. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Dinucleotide repeat polymorphism at the human MHC class I CD8 alpha-chain (Leu-2, T8) gene. Nucleic Acids Res 1991: 19: 1718.
68. Wu S, Comings DE. G5644A polymorphism in the interferon-gamma (INFG) gene. Psychiatry Genet 1998: 8: 57.